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Abstract
Background: Immunoglobulin E (IgE) is a central player in the allergic response, and raised total IgE levels are considered as
an indicator of atopy or potential development of atopy. A recent genome-wide scan in a German population-based cohort
of adults identified the gene encoding the alpha chain of the high affinity receptor for IgE (FCER1A) as a susceptibility locus
influencing total serum IgE levels. The aim of this study was to investigate whether the polymorphisms in the FCER1A gene
are associated with allergic rhinitis (AR) in a Han Chinese population.
Methodology/Principal Findings: A population of 378 patients with AR and 288 healthy controls was studied. Precise
phenotyping of patients was accomplished by means of a questionnaire and clinical examination. Blood was drawn for DNA
extraction and total serum immunoglobulin E (IgE) measurement. A total of 16 single nucleotide polymorphisms (SNPs) in
FCER1A were selected and individually genotyped. None of the SNPs in the FCER1A showed an association with AR.
Similarly, the lack of association was also evident in subgroup analysis for the presence of different allergen sensitivities.
None of the selected SNPs in FCER1A was associated with total IgE level.
Conclusions: Although FCER1A presents itself as a good candidate for contributing to total serum IgE, this study failed to
find an association between SNPs in the FCER1A gene region and IgE level or AR susceptibility.
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Introduction
Allergic rhinitis (AR) is an inflammatory disease of the nasal
mucosa induced by an immunoglobulin E (IgE)-mediated reaction
in allergen-sensitized subjects. It is a disease of high prevalence,
especially in industrialized countries, and has exhibited a fairly
rapid upward trend [1]. Recent data on self-reported AR in the
centre of cities across mainland China demonstrated a prevalence
of 8.7%–24.1% [2]. This high prevalence translates into a
considerable cost to society in terms of overall healthcare use
and the quality of life of those with moderate-to-severe disease.
The reasons for these trends remain unclear but probably reflect
environmental influences on genetic predisposition.
High total serum IgE levels are closely correlated with the
clinical expression and severity of asthma and allergy [3,4]. The
regulation of serum IgE production is largely influenced by
familial determinants, and both pedigree- and twin-based studies
provide evidence of a strong genetic contribution to the variability
of total IgE levels [5,6]. Genetic susceptibility to IgE-responsive-
ness is likely to be caused by a pattern of polymorphisms in
multiple genes regulating immunological responses [7], but so far
only a very few loci have been established consistently and
robustly [8,9]. Very recently, a genome-wide scan in a German
population-based cohort of adults identified the gene encoding the
alpha chain of the high affinity receptor for IgE (FCER1A) on
chromosome 1 as a susceptibility locus which was associated with
total serum IgE levels [10]. Moreover, Chen et al. also found that
a common variant in FCER1A was associated with total serum
IgE levels found in cord blood and up to the first six years of life,
and this was demonstrated to be independent of environmental
stimuli [11].
We hypothesized that FCER1A could be a strong candidate
gene for influencing total serum IgE level and that single
nucleotide polymorphisms (SNPs) in the FCER1A gene region
may influence the risk of developing AR. Therefore, in an
attempt to identify whether and how polymorphisms in the
FCER1A gene are associated with AR, we conducted a
population-based case-control association analysis to assess the
risk of AR conferred by SNPs in the FCER1A gene region in a
Han Chinese cohort.
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Population characteristics
The characteristics of the study population are shown in
Table 1. Age and gender were well-balanced between cases and
controls. The cohort of 378 AR patients had a mean age of 27
years and consisted of more men (60.1%) than women (39.9%),
while the 288 control individuals had a mean age of 37 years, with
a similar component of more men (56.1%) than women (43.9%).
The mean total serum IgE measurements for the case and control
groups were 292.36529.8 and 58.26111.7 IU/ml respectively.
Patients were diagnosed as having AR by combining the skin test
and serum specific IgE data with the allergen-specific case history
and physical nasal examination. 83.1% of individuals demonstrat-
ed perennial nasal symptoms while the remainder reported
seasonally-related reactions. When subjects were classified accord-
ing to the serum allergen-specific IgE category, 216 (56.6%), 64
(16.9%) and 100 (26.5%) were allergic to house dust mites (HDM),
pollens and mixed allergens respectively. We defined mixed
allergen allergy to be when an individual showed positive
responses to two or more allergens in the skin test or serum
examination.
Single marker association analysis of FCER1A SNPs with
AR susceptibility
We genotyped SNPs in the FCER1A gene, tagging three blocks
(Figure 1). One SNP, rs2298805 (exact P=0.0071) was not in
Hardy-Weinberg equilibrium (HWE) in controls and was excluded
from further analysis. The analysis of allele frequencies for the
remaining 15 SNPs tested, shown in Table 2, revealed no
significant associations (P,0.05) with an AR outcome in the
FCER1A gene. Meanwhile, results for the analysis of association
between the related genotypes of each SNP and AR susceptibility
were also obtained, again indicating a lack of evident association
(Table 2). Although none of the SNPs showed evidence of
association, rs2251746 (Pallele=0.0659; Pgenotype=0.0688) and
rs2427837 (Pallele=0.0865; Pgenotype=0.0904) exhibited relatively
lower P values among the 15 selected SNPs (Figure 2). Likewise,
stratifying the AR cohort and controls by the presence of
sensitivity to different allergens failed to detect any evidence of
association between the genotyped SNP markers and AR (Table
S1). In addition, none of the 15 SNPs in the FCER1A gene was
associated with serum total IgE level (Table 3).
LD and haplotype analysis
To assess the extent of linkage disequilibrium (LD) across the
FCER1A gene, we calculated D9 values. Some of the pair-wise D9
values in the FCER1A gene were close to 1 among all SNPs,
indicating very strong LD. As the SNPs were in 3 different LD
blocks, the haplotypes of the markers of the FCER1A gene were
analyzed separately. Among all the haplotypes which were
predicted, only 15 had a frequency above 1%. Again, no
significant difference was detected between AR cases and healthy
controls (Table 4).
Discussion
Our study aimed to evaluate the contribution of single
nucleotide polymorphisms (SNPs) in the FCER1A gene region
to allergic rhinitis (AR) susceptibility in a Chinese population-
based case-control association analysis. The impact of common
FCER1A SNPs on AR susceptibility was first measured in the
Chinese cohort. Our data shows no associations between SNPs in
the FCER1A gene region and AR.
Allergic sensitization is defined by production of immunoglob-
ulin E (IgE) against environmental antigens such as house dust
mite, grass pollen, and animal proteins and can lead to diseases
that include asthma, rhinitis and atopic dermatitis [12]. A key
feature of these diseases is an IgE-mediated aberrant immune
responsiveness to otherwise harmless environmental allergens,
with the majority of patients exhibiting increased total and
allergen-specific IgE levels [13]. Numerous metabolic networks
can contribute to IgE production, but their complex interactions
are not well understood at present [14].
FCER1Aisanimportantimmunity-relatedgenethat encodesthe
ligand-binding subunit of the high-affinity IgE receptor (FceRI), the
a-chain(FceRIa) [15].Thus,recentstudies havefocused notonlyon
human FCER1A gene variability [16–22], but also on polymor-
phisms of its counterparts in animals [23.24]. Hasegawa first
reported that a significant portion of nonallergic individuals has
heterozygous 266T/C genotype of rs2251746 in FCER1A gene,
while most of allergic individuals have homozygous 266T/T
genotype in Japanese population in 2003 [17]. Moreover, in a
recent population-based GWAS,,a functional promoter variant
affecting FCER1A expression (rs2251746) and a tightly-linked
variant (rs2427837) were found to be highly associated with total
serum IgE levels, a finding that was replicated in more than 10 000
individuals from four independent population-based cohorts [10].
In a subsequent independent replication study on two Germanbirth
cohorts, they showed that these variants were strongly associated
with basal IgE production independently of environmental stimuli
and at different stages of life, operating as early as during the fetal
period [11]. Very recently, Mahachie et al. reported that three
strongly-correlated FCER1A polymorphisms were significantly
associated with total and specific IgE levels as well as with allergic
sensitization, suggesting that FCER1A variants, either alone or in
combination, influence IgE levels and actsynergistically to influence
eczema risk [25].
The extent of the impact of polymorphisms on FCER1A
function and properties is under investigation. Many atopy-
associated SNPs within the promoter of FCER1A have been
reported to determine transcriptional activity and subsequently
receptor expression. In particular, FceRIa 2344(2315)1 C.T
(rs2427827) polymorphism was found to be associated with
aspirin-induced urticaria [21] and with total serum IgE levels in
different groups of allergic subjects [16,18,19,21]. Notably, in a
previous study with Japanese individuals it could be shown that the
minor allele of the polymorphism FCER1A proximal promoter
Table 1. Demographic characteristics of the study
population.
Characteristic AR cases (n=378) Controls (n=288)
Age Mean (Range) (years) 26.9614.8 (2–71) 36.3615.2 (3–78)
Sex, M/F, No. (%) 227 (60.1)/151 (39.9) 161 (56.1)/126
(43.9)
Total IgE Mean (Range), kU/l 292.36529.8 (6.94–5000) 58.26111.7 (2–906)
Perennial/seasonal, No.(%) 314 (83.1)/64 (16.9) /
Allergen category, No. (%)
House dust mite 214 (56.6) /
Pollens 64 (16.9) /
Mixed allergens 100 (26.5) /
‘‘/’’: no results.
doi:10.1371/journal.pone.0015792.t001
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rs2427827 is associated with higher FCER1A expression through
enhanced GATA-1 binding [17]. Both of these frequent
polymorphisms were demonstrated to strongly affect FCER1A
expression in mast cells and/or basophils in an additive manner
[17,21,22], thus providing a partial mechanistic background for
the genetic associations described above. In addition, the frequent
218483A.C (rs2494262) polymorphism was also found to be
associated with total serum IgE levels in allergic subjects [18–20].
Very recently, Potaczek et al found that we confirmed preferential
binding of the YY1 transcription factor to the 218483C allele,
resulting in lower transcriptional activity when compared with the
218483A allele [26].
Total IgE is a strongly heritable quantitative trait [27,28]. In
contrast to the considerable genetic and phenotypic heterogeneity
at the level of allergic disease, total IgE represents a more defined
and quantifiable endophenotype. Although not without contro-
versy, it is commonly thought that it is useful to study such low-
level physiological traits associated with the higher-order diseases
of interest, because they probably involve fewer genes and fewer
interacting levels, and eventually provide simpler clues to an
enhanced functional understanding of the genetics of the more
complex diseases [29,30]. Interestingly, although in this study we
did not detect associations between FCER1A variants and total
IgE level or AR, rs2251746 and rs2427837 exhibited the highest P
values for associations among the 15 selected SNPs in our data.
This is similar to Weidinger’s GWAS, which identified rs2251746
and rs2427837 as being strongly associated with total IgE levels in
all cohorts with significant P values and found that these two SNPs
were in a complete LD.
Furthermore, it is important to note that the lack of association
in this study does not completely rule out FCER1A as an AR
candidate gene. The statistical power of sample size in this study
was only 77.85% as regards the association analysis. However, it
could be that SNPs in the FCER1A gene region confer a smaller
risk of developing AR. Future efforts to identify FCER1A SNPs
carrying a smaller FCER1A risk will require a larger sample size
than has been used here. Moreover, as with many other complex
disorders, AR is thought to be the result of a complicated network
of numerous susceptibility loci, many of which exert additive or
Figure 1. Pairwise Linkage Disequilibrium (LD) between tagging SNPs for the FCER1A gene. The LD plots were generated by Haploview
4.1. The white horizontal bar below the info track illustrates the location of SNPs on a physical scale. The value within each diamond represents the
pairwise correlation between tagging SNPs defined by the upper left and the upper right sides of the diamond. Shading represents the magnitude
and significance of pairwise LD, with a red-to-white gradient reflecting higher to lower LD values.
doi:10.1371/journal.pone.0015792.g001
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isolation [31,32]. Among other reasons, failure to identify and
replicate individual genetic risk factors for complex diseases has
been attributed to epistasis obscuring the effect of single loci
[33,34]. Designing suitable analytical strategies to identify multi-
SNP interactions in addition to factors that exhibit an independent
effect is also one of the main challenges for GWASs. However, it is
important to note that based on the current study, a particular
FCER1A variant alone does not show a significant association
with the development of AR. Further studies including gene-gene
and gene-environment interactions in AR cohorts are needed to
clarify the impact of FCER1A on atopic disease.
In conclusion, currently there is no genetic evidence to suggest
that polymorphisms in the FCER1A gene region confer
susceptibility to AR or IgE levels in a Han Chinese population.
Materials and Methods
Study subjects
Three hundred and seventy-eight individuals (227 males and
151 females) with AR were prospectively recruited from the
rhinology clinic and ward of Beijing TongRen Hospital and the
Allergy and Immunotherapy Center of The General Hospital of
Shenyang Military Command from February 2008 to July 2009.
Individuals with accompanying allergic diseases such as asthma
and atopic dermatitis were excluded from the study. A total of 288
controls who were healthy volunteers were recruited from an
ethnically-similar local population to determine similar back-
ground population allele frequencies. All subjects were of Han
Chinese ethnic origin and all from the northern region of China.
The study was approved by the Ethics Committees of Beijing
TongRen Hospital and The General Hospital of Shenyang
Military Command, and written informed consent was obtained
from all participants.
Patients were diagnosed as having AR if they tested positive for
all three of the following criteria from the ARIA (Allergic Rhinitis
and its Impact on Asthma, 2008) [35] guidelines. 1) persistent or
discontinuous symptoms of anterior rhinorrhea, continuous
sneezing, nasal obstruction and itching, 2) local nasal cavity signs,
including discolored and edematous mucosa and watery drainage
in the common or middle nasal meatus and 3) positive serum
antigen-specific IgE as measured by the ImmunoCAP 100 system
Table 2. Allele and genotype frequencies and AR susceptibility.
SNP Minor allele Case, Control Frequencies Allele P-value Genotype P-value
rs2494262(A/C) C 0.2715, 0.2780 0.7961 0.8875
rs2427836(C/T) C 0.1953, 0.1895 0.796 0.3782
rs2494263(A/G) G 0.1619, 0.1448 0.4242 0.3640
rs16841979(C/G) C 0.0822, 0.0743 0.6045 0.7709
rs2427837(A/G) A 0.0417, 0.0629 0.0865 0.0904
rs12565775(A/C) A 0.4432, 0.4477 0.8743 0.8446
rs2494264(A/T) A 0.2201, 0.2428 0.3386 0.5990
rs11809585(A/T) T 0.0880, 0.0978 0.5485 0.8247
rs2251746(C/T) C 0.0403, 0.0629 0.0659 0.0688
rs2298804(A/G) G 0.0376, 0.0290 0.3999 0.2440
rs2494265(A/T) A 0.2028, 0.1848 0.4221 0.6440
rs2269718(A/G) A 0.4391, 0.4239 0.5887 0.8591
rs2494251(A/G) A 0.2799, 0.2709 0.7213 0.6810
rs11265165 (C/T) C 0.4319, 0.4388 0.8052 0.8185
rs12562171(C/T) C 0.3663, 0.3687 0.9295 0.9815
doi:10.1371/journal.pone.0015792.t002
Figure 2. Significance of each tagging SNP. The x axis shows the genomic position, and the y axis shows the negative base-10 logarithm of the
P values for each allele and genotype of each SNP. Lines are drawn between points only for the sake of clarity, as the disease association between
markers is not linear.
doi:10.1371/journal.pone.0015792.g002
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(SPT) (Allergopharma, Reinbeck, Germany). The antigens
included house dust mite (HDM) (Dermataphagoides farinae and D.
pteronyssinus); seasonal grass pollens (Giant Ragweed; Mugwort;
Lamb’s quarters; Humulus; Chenopodium album, etc.); animal hair
(especially dog and cat); molds (indoor and outdoor mustiness or of
floriculture), and cockroach. Subjects were considered to be
sensitive to allergens if the measurement of serum IgE was equal to
or above 0.35 kU/l. A positive SPT result was defined as a wheal
greater than or equal to one half of the diameter of the histamine
control and at least 3 mm larger than the diameter of the negative
control [36]. Serological and skin testing were performed by
specialist technicians and nurses respectively, while the AR
diagnoses were made by clinical rhinologists. The controls
presented no clinical features, local nasal cavity signs, family
history of AR and showed negative of serum antigen-specific IgE
phadiatop determination.
Selection of polymorphisms in the human FCER1A gene
The International Haplotype Mapping (HapMap) (www.
hapmap.org) SNP databases were used to select SNPs in the
FCER1A gene region. The screened region was extended
10 kilobases upstream of the annotated transcription start site
and downstream at the end of the last FCER1A exon. The SNPs
were selected to extract the most genetic information based on
CHB haplotype data using the HAPMAP database (Hapmap Data
Rel 27 Phase II+III, Feb09) [37]. From this dataset, 29 SNPs in
the FCER1A gene region were selected using a pairwise tagging
algorithm implemented in Haploview software version 4.1 [38]. In
addition, when we set the Hardy-Weinberg p value cutoff, minor
allele frequency and r
2 thresholds at 0.01, 0.05 and 0.8,
respectively, the linkage disequilibrium (LD) pattern for the
FCER1A gene in our population exhibited strong LD in several
groups of SNPs, indicating that the SNPs in each group represent
a common region. Consequently, we choose rs2494265,
rs12565775, rs2269718, rs2494264, rs11265165, rs2494262,
rs12562171, rs2494263 rs11809585, rs16841979, rs2298804,
rs2298805, rs2427836 and rs2494251 to represent the entire 29
loci for eventual genotyping. Two additional SNPs (rs2251746,
rs2427837) from a previous study were also included [10].
Therefore, 16 SNPs constituted the selection set to be genotyped
in our patient and control groups.
Single nucleotide polymorphism genotyping
DNA was isolated from peripheral blood leukocytes and
collected in EDTA-treated tubes, using the DNA Isolation Kit
for Mammalian Blood(Roche, Indianapolis, USA). Isolated DNA
from blood was stored at 4uC prior to use. The majority of the
selected SNP genotyping was performed using the Sequenom
MassARRAY iPLEX Gold platform (Sequenom, San Diego,
California) according to the manufacturer’s instructions. The
polymerase chain reaction (PCR) and extension primers were
designed using MassARRAY Assay Design 3.1 software (for details
see Table S2). One SNP (rs2494863), which was evaluated by
preliminary testing as unsuitable for genotyping through the
MassArray approach was identified by direct sequencing of the
PCR products of genomic DNA. Genotyping was performed
without knowledge of the case or control status. A 10% random
sample was tested in duplicate by different persons, and the
reproducibility was 100%.
Statistical analyses
Hardy-Weinberg equilibrium (HWE) of each SNP was assessed
in controls using a chi–square test with one degree of freedom
using Haploview 4.1. A threshold of P,0.05 was considered to
indicate deviation from HWE. SPSS software version 13.0 was
used to determine association. Chi-square tests were performed to
determine whether an association existed between cases and
controls. Haplotype association analysis was performed using
SHEsis, a web-based software platform that allowed the
estimation of haplotype frequencies. Associations with suscepti-
bility to AR were tested by calculating odds ratios (OR) with
Table 3. Association between FCER1A SNPs and IgE levels.
SNP P for Levene Statistic F P-value
rs2494262 ,0.001 1.653* 0.438*
rs2427836 0.294 0.695 0.556
rs2494263 0.087 1.181 0.317
rs16841979 0.824 0.238 0.917
rs2427837 0.632 0.185 0.906
rs12565775 0.771 0.149 0.931
rs2494264 0.219 0.743 0.563
rs11809585 0.669 1.081 0.366
rs2251746 0.651 0.157 0.925
rs2298804 0.639 0.254 0.907
rs2494265 0.218 0.550 0.699
rs2269718 0.054 0.832 0.505
rs2494251 0.038 1.641* 0.44*
rs11265165 0.243 0.498 0.684
rs12562171 0.009 1.137* 0.566*
‘‘*’’: results using Kruskal-Wallis ANOVA.
doi:10.1371/journal.pone.0015792.t003
Table 4. Haplotype frequencies and AR susceptibility.
Haplotype Case Fr Control Fr df Chi Square P-Value
Block 1
AT 0.533 0.532 1 0.001 0.9788
CT 0.271 0.278 1 0.067 0.7961
AC 0.195 0.190 1 0.067 0.796
Block 2
GGCTATTA 0.358 0.346 1 0.189 0.6635
GGATATAG 0.200 0.181 1 0.729 0.3932
GGCTATTG 0.117 0.127 1 0.312 0.5764
GGAATTTG 0.084 0.098 1 0.759 0.3836
GGAAATTG 0.093 0.081 1 0.572 0.4496
CGCTATTA 0.079 0.074 1 0.135 0.7136
GAAAACTG 0.040 0.062 1 3.029 0.0818
GGATATTG 0.021 0.024 1 0.11 0.7403
Block 3
GCC 0.362 0.361 1 0 0.9939
GTT 0.285 0.286 1 0.002 0.9624
ATT 0.280 0.268 1 0.215 0.6432
GCT 0.070 0.076 1 0.185 0.6675
df: degree of freedom.
doi:10.1371/journal.pone.0015792.t004
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values less than 0.05 were considered statistically significant.
Furthermore, subanalysis restricted to the presence of different
allergens - house dust mite, pollens and mixed allergens - was also
performed to examine whether the effect of associations within
the population differed among the subgroups. Associations
between genotype and IgE levels for all AR and control subjects
were assessed using an ANOVA test. Homogeneity of variance
test was made using Levene test firstly. A threshold of P for
Levene Statistic ,0.05 was considered to indicate a non-normal
distribution of IgE level. Kruskal-Wallis ANOVA was used for
association of FCER1A SNPs with non-normal distribution IgE
levels. The statistical power for the present study was calculated
using G*Power 2 software (http://www.psycho.uni-duesseldorf.
de/aap/projects/gpower/). When the parameter was set on 0.2
which represented the effect of the gene was minor, the power of
the present collected sample size as regarding the association
study was evaluated.
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